CATEGORIES

Coronavirus

LATEST

TRENDING

EDITORS CHOICE

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

Dallas UT Southwestern Finds First Case of Brazil P.1 Variant in North Texas

UT Southwestern scientists in Dallas announced concerning news in the fight against Covid-19. The medical school identified the first North Texas case of the Brazil P.1 Covid-19 strain in North Texas.

Why Won’t More Older Americans Get Their Covid Booster?

A central question for scientists championing boosters is why rates have stalled among people 65 and older.

The Story of The Un-Vaccinated

Whenever I got sick as a child, I never hesitated to take Robitussin. Why? Because I believed that the medication I was taking would...